News

Group refines existing opioid misuse risk assessment tool


 

AT THE AAPM ANNUAL MEETING

Dr. Gostine said that he is planning to publish the findings. After refinement of the ORT, which is currently in the public domain and available to physicians, the tool might expand to 15 questions – a short-enough questionnaire that patients can fill out in 2 or 3 minutes. If the questionnaires are fed into electronic medical records, as they are in Dr. Gostine’s practice, "the doctor can find out whether [the patient] is someone they should be nervous about or someone they can trust" when it comes to prescribing opioids.

Dr. Gostine and his partner, Dr. Fred Davis, developed the Prism Pain Health Assessment that was used to capture and analyze the data. The product is now commercially available. Dr. Webster has received honoraria/travel support from AstraZeneca, Covidien Mallinckrodt, and other companies.

nmiller@frontlinemedcom.com

On Twitter @naseemsmiller

Pages

Recommended Reading

Panel votes against hydrocodone because of abuse potential
MDedge Rheumatology
FDA panel backs more restricted hydrocodone prescribing
MDedge Rheumatology
VIDEO: Marijuana may raise stroke risk
MDedge Rheumatology
Cognitive dysfunction, psychosis respond equally in pediatric SLE
MDedge Rheumatology
All glucocorticoids linked to increased risk of VTE
MDedge Rheumatology
FDA backs abuse-deterring OxyContin, thwarts generics
MDedge Rheumatology
Most pain apps lack physician input
MDedge Rheumatology
Eight principles for safe opioid prescribing
MDedge Rheumatology
Preimmunosuppresive hepatitis B screening often goes by the wayside
MDedge Rheumatology
VITAMINS mnemonic simplifies neurologic diagnoses in lupus, Sjögren's
MDedge Rheumatology